公开(公告)号：US07985562B2

公开(公告)日：2011-07-26

申请号：US12474794

申请日：2009-05-29

申请人： Detlef Kozian ,  Stefan Schaefer ,  Bernward Schoelkens ,  Karl-Ernst Siegler ,  Jean-Francois Deleuze ,  Sylvain Ricard ,  Sandrine Mace

发明人： Detlef Kozian ,  Stefan Schaefer ,  Bernward Schoelkens ,  Karl-Ernst Siegler ,  Jean-Francois Deleuze ,  Sylvain Ricard ,  Sandrine Mace

IPC分类号： G01N33/00

CPC分类号： G01N33/6893 ,  Y10S436/811

摘要： The present invention is directed to a method identifying a risk for a thrombogenic disorder, to a method for selecting patients with a risk for a thrombogenic disorder, to a method for identifying a pharmaceutical for the therapy or prophylaxis of a thrombogenic disorder as well as to a method for producing a medicament and a diagnostic by employing the TAFI-Ile347 polymorphism.

摘要翻译： 本发明涉及一种鉴定血栓形成疾病风险的方法，选择患有血栓形成疾病风险的患者的方法，用于鉴定用于治疗或预防血栓形成疾病的药物的方法，以及 通过采用TAFI-Ile347多态性制备药物和诊断方法。